Logo image
Perspective From the 5th International Pemphigus and Pemphigoid Foundation Scientific Conference
Journal article   Open access   Peer reviewed

Perspective From the 5th International Pemphigus and Pemphigoid Foundation Scientific Conference

Jinmin Lee, Victoria P Werth, Russell P Hall, Rüdiger Eming, Janet A Fairley, David C Fajgenbaum, Karen E Harman, Marcel F Jonkman, Neil J Korman, Ralf J Ludwig, …
Frontiers in medicine, Vol.5, pp.306-306
11/08/2018
DOI: 10.3389/fmed.2018.00306
PMCID: PMC6236000
PMID: 30467542
url
https://doi.org/10.3389/fmed.2018.00306View
Published (Version of record) Open Access

Abstract

The 5th Scientific Conference of the International Pemphigus and Pemphigoid Foundation (IPPF), “Pemphigus and Pemphigoid: A New Era of Clinical and Translational Science” was held in Orlando, Florida, on May 15–16, 2018. Scientific sessions covered recent, ongoing, and future clinical trials in pemphigus and bullous pemphigoid, disease activity and quality of life instruments, and the IPPF Natural History Study. Furthermore, the meeting provided an opportunity to hear firsthand from patients, investigators, and industry about their experience enrolling for clinical trials.
Medicine T-cell leukotriene Btk FcRn eotaxin doxycycline rituximab fumarate

Details

Metrics

Logo image